Sensitivity analyses.

<p>Sensitivity analyses.</p

Maximal adversity exposure groups and the risk of suicide.

<p>Maximal adversity exposure groups and the risk of suicide.</p

Kaplan-Meier survival curve for the cumulative probability of suicide risk for the indirect, in utero only, in utero and postnatal and late postnatal exposure subgroups.

<p>Note. The curves depict average age of suicide for the exposure groups based on Kaplan-Meier modeling estimates. The vertical axis is the proportion that did not complete suicide. The numbers under the horizontal axis are age, and the numbers above the x-axis are the numbers at risk every 15 years.</p

Kaplan-Meier survival curve for the cumulative probability of suicide risk for the indirect, partial and direct exposure groups.

<p>Note. The curves depict average age of suicide for the exposure groups based on Kaplan-Meier modeling estimates. The vertical axis is the proportion that did not complete suicide. The numbers under the horizontal axis are age, and the numbers above the x-axis are the numbers at risk every 15 years.</p

Clinical practice implications of mhGAP recommendations.

<p>Clinical practice implications of mhGAP recommendations.</p

Abridged recommendations for epilepsy and seizures (EPI 1–12).

<p>CFS, complex febrile seizures; EEG, electroencephalography; IM, intramuscular; IV, intravenous.</p

Abridged recommendations for dementia (DEM 1–10).

<p>Abridged recommendations for dementia (DEM 1–10).</p

Abridged recommendations for child and adolescent mental health conditions (CAMH 1–13).

<p>Abridged recommendations for child and adolescent mental health conditions (CAMH 1–13).</p

Abridged recommendations for self-harm and suicide (SUI 1–9).

<p>Abridged recommendations for self-harm and suicide (SUI 1–9).</p

Abridged recommendations for psychosis and bipolar disorders (PSY 1–13).

<p>Abridged recommendations for psychosis and bipolar disorders (PSY 1–13).</p